Back to search

Article

Efficacy of Dual Antiplatelet therapy depending on hsCRP levels and CYP2C19 Genotype

2022-08-01

Abstract excerpt

<h4>Background: </h4> Both high-sensitive C-reactive protein (hsCRP) and CYP2C19 genotypes are independent predictors of clinical outcomes after ischemic stroke. We aim to evaluate the association of CYP2C19 loss-of-function alleles (LoFA) carrying status with the effects of dual/single antiplatelet therapy at different hsCRP levels using the High-Risk Patients with Acute Non-disabling Cerebrovascular Events (CHAN...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
89c14d1d-ebc6-5a58-a844-9241bfebc7f8
DOI
10.21203/rs.3.rs-1893856/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy of Dual Antiplatelet therapy depending on hsCRP levels and CYP2C19 GenotypeDOI 10.21203/rs.3.rs-1893856/v1
Efficacy of dual antiplatelet therapy after ischemic stroke according to hsCRP levels and CYP2C19 genotype.Semantic proximity
Genotype-guided ticagrelor/prasugrel versus clopidogrel therapy in stroke patients with CYP2C19 loss of function alleles: a systematic review and meta-analysis.Semantic proximity
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies.Semantic proximity
The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack.Semantic proximity
Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack.Semantic proximity
Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.Semantic proximity
Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial.Semantic proximity
Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel.Semantic proximity
Post-Percutaneous Coronary Intervention CYP2C19 Genotyping: The Potential Role In Identifying Clopidogrel Therapy Related Bleeding RisksSemantic proximity
Clopidogrel preventive effect based on cytochrome P450 2C19 genotype in ischaemic stroke: protocol for multicentre observational study.Semantic proximity
Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping.Semantic proximity
The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis.Semantic proximity
Select a neighboring publication to make it the new centre.